Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from ConvaTec ( (GB:CTEC) ) is now available.
ConvaTec Group PLC has executed a share buyback, purchasing 1,075,326 ordinary shares as part of its $300 million share buyback program announced in August 2025. The shares, bought at a volume-weighted average price of 239.32 pence, will be held in treasury, impacting the company’s total voting rights and potentially influencing shareholder interests.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.
ConvaTec’s strong financial performance and strategic positioning are tempered by bearish technical indicators and a high valuation. Regulatory challenges may pose risks, but the company’s innovation pipeline and operational strength support a moderately positive outlook.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products industry, specializing in the development and manufacturing of products for wound care, ostomy care, continence and critical care, and infusion devices. The company focuses on providing innovative solutions to improve the lives of patients and healthcare professionals globally.
Average Trading Volume: 7,845,026
Technical Sentiment Signal: Hold
Current Market Cap: £4.8B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.